Biosimilar oligosaccharides to restore microbiome diversity
Gnubiotics Sciences SA
Incorporated
08.09.2016Headquarters
EpalingesSupport
Gnubiotics Sciences SA is revolutionizing the microbiome health of humans and animals with a new category of complex molecules: glycans. Gnubiotics' unique and proprietary technology platform combines the power of chemistry and genomics to develop glycans that are proving to have unparalleled efficacy in restoring microbiome equilibrium, enabling the host to harness its power.
News
Gnubiotics attracts nobel prize winner as advisor ahead of clinical trials (startupticker.ch)
Gnubiotics wins first commercial customer for AMOBIOME (startupticker.ch)
Companies worldwide look to Switzerland for tech solutions (startupticker.ch)
Startups welcome executives aboard (startupticker.ch)
The first cohort for the Venture Leaders Biotech roadshow revealed (startupticker.ch)
Gnubiotics Sciences bags CHF 2.6 million (startupticker.ch)
Die Finalisten des Swiss Economic Award stehen fest (startupticker.ch)
GNUbiotics scales up production with renowned partner (startupticker.ch)
With its first product Gnubiotics aims to improve pets? gut health (startupticker.ch)
Gnubiotics Sciences raises CHF 2.3 million (startupticker.ch)
First companies selected for StartLab incubator (startupticker.ch)
Milestones news
Gnubiotics Sciences converted CHF 3.7 million loans into shares and move to SA
Convertible debt bearing interest
Documents
Videos and Presentations
Discover microbiota modulation via natural mechanism of action